These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 14986047

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.
    Catalona WJ, Smith DS, Ornstein DK.
    JAMA; 1997 May 14; 277(18):1452-5. PubMed ID: 9145717
    [Abstract] [Full Text] [Related]

  • 4. Clinical usefulness of free PSA in early detection of prostate cancer.
    Luboldt HJ, Swoboda A, Börgermann C, Fornara P, Rübben H, Early Detection Project Group of the German Society of Urology.
    Onkologie; 2001 Feb 14; 24(1):33-7. PubMed ID: 11441278
    [Abstract] [Full Text] [Related]

  • 5. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M.
    J Urol; 1998 Aug 14; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [Abstract] [Full Text] [Related]

  • 6. Use of percent free prostate-specific antigen density to improve the specificity for detecting prostate cancer in patients with normal rectal examinations and intermediate prostate-specific antigen levels.
    Baltaci S, Aksoy H, Türkölmez K, Elhan AH, Ozden E, Göğüş O.
    Urol Int; 2003 Aug 14; 70(1):36-41. PubMed ID: 12566813
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A, Dworschack RT, Partin AW.
    J Urol; 2002 Aug 14; 168(2):504-8. PubMed ID: 12131298
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels.
    Dinçel C, Caşkurlu T, Taşçi AI, Cek M, Sevin G, Fazlioğlu A.
    Int Urol Nephrol; 1999 Aug 14; 31(4):497-509. PubMed ID: 10668945
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J, Raventós CX, Lorente JA, Lopez-Pacios MA, Encabo G, de Torres I, Andreu J.
    J Urol; 1997 Aug 14; 158(2):502-4. PubMed ID: 9224333
    [Abstract] [Full Text] [Related]

  • 13. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
    Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC.
    J Urol; 1994 Dec 14; 152(6 Pt 1):2031-6. PubMed ID: 7525994
    [Abstract] [Full Text] [Related]

  • 14. The percentage of free prostatic-specific antigen is also useful in men with normal digital rectal examination and serum prostatic-specific antigen between 10.1 and 20 ng/ml.
    Morote J, Trilla E, Esquena S, Serrallach F, Abascal JM, Muñoz A, Id M'Hammed Y, de Torres IM.
    Eur Urol; 2002 Oct 14; 42(4):333-7. PubMed ID: 12361897
    [Abstract] [Full Text] [Related]

  • 15. Prospective evaluation of prostate specific antigen density and systematic biopsy for detecting prostate cancer in Japanese patients with normal rectal examinations and intermediate prostate specific antigen levels.
    Arai Y, Maeda H, Ishitoya S, Okubo K, Okada T, Aoki Y.
    J Urol; 1997 Sep 14; 158(3 Pt 1):861-4. PubMed ID: 9258099
    [Abstract] [Full Text] [Related]

  • 16. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
    Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT, Lange PH, Subong EN, Parson RE, Gasior GH, Loveland KG, Southwick PC.
    JAMA; 1998 May 20; 279(19):1542-7. PubMed ID: 9605898
    [Abstract] [Full Text] [Related]

  • 17. [Diagnostic algorithm based on a multivariate model to reduce the percentage of negative prostatic biopsies in patients with changed PSA or suspicious rectal palpation].
    Valer Algarabel J, Agüera Fernández L, Adot Zurbano JM, Virseda Chamorro M, Marcos Díez J, Gómez López A, Alpuente Román C.
    Actas Urol Esp; 2000 May 20; 24(7):549-59. PubMed ID: 11011445
    [Abstract] [Full Text] [Related]

  • 18. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B, Alkibay T, Tuncel A, Bozkirli I.
    Can J Urol; 2000 Oct 20; 7(5):1104-9. PubMed ID: 11114873
    [Abstract] [Full Text] [Related]

  • 19. Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen.
    Morgan TO, McLeod DG, Leifer ES, Murphy GP, Moul JW.
    Urology; 1996 Dec 20; 48(6A Suppl):76-80. PubMed ID: 8973705
    [Abstract] [Full Text] [Related]

  • 20. Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies.
    Catalona WJ, Beiser JA, Smith DS.
    J Urol; 1997 Dec 20; 158(6):2162-7. PubMed ID: 9366336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.